Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000919574-16-009285
Filing Date
2016-01-14
Accepted
2016-01-14 16:14:21
Documents
1
Period of Report
2016-01-12

Document Format Files

Seq Description Document Type Size
1 REDMILE/ARRY p7000681.html 4  
1 REDMILE/ARRY p7000681.xml 4 5627
  Complete submission text file 0000919574-16-009285.txt   7556
Mailing Address 3200 WALNUT STREET BOULDER CO 80301
Business Address 3200 WALNUT STREET BOULDER CO 80301 3033816600
ARRAY BIOPHARMA INC (Issuer) CIK: 0001100412 (see all company filings)

EIN.: 841460811 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129
Business Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129 415-489-9980
Redmile Group, LLC (Reporting) CIK: 0001425738 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-16633 | Film No.: 161343112

Mailing Address ONE LETTERMAN DRIVE, BUILDING D SUITE D3-300 SAN FRANCISCO CA 94129
Business Address
Green Jeremy (Reporting) CIK: 0001650527 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-16633 | Film No.: 161343111